Intra-abdominal pressure (IAP) is prevalent in critically ill patients, has negative effects on all signaling pathways, and is linked to a high rate of morbidity and mortality. Patients with intra-abdominal hypertension (IAH) and/or Abdominal Compartment Syndrome (ACS) demand serial IAP measurements for diagnosis, treatment, and fluid resuscitation. Intravesical Pressure (IVP) is easily measured and should be monitored in any patient who is viewed as having a substantial increase in IAP. IAP devices help with early identification of ACS as a result to treat it in the initial stage thereby reducing mortality to a greater extent. The IAP measurement device market is set to flourish as a result of increased IAH related hospitalization across regions including Europe.
Rising number of Geriatric Population
Market Growth Drivers:
Prevalence of Chronic and Infectious Diseases Including Abdominal Compartment Syndrome (ACS) and Increasing Intra-Abdominal Hypertension Cases
Number of Complications Associated to Procedure
The key Players profiled in the report are CR. Bard Inc. (United States), ConvaTec Group PLC (United Kingdom), Stryker Corporation (United States), Biometrix Ltd. (Netherlands), Medline Industries (United States), Potrero Medical (United States), Spiegelberg GmbH & Co. KG (Germany), Nutrimetics (Australia), Gaeltec Devices Ltd. (United Kingdom), Bamford & Co Ltd (New Zealand) and Holtech Medical (Denmark).